CSF1 is essential for the survival and differentiation of macrophages, as was shown by Pyonteck et al. (2013), where a cohort of treated mice with glioma survived a median of 5.7 weeks, while 64.3% of those treated with CSF1 blockade were still alive at 26 weeks [128]. The gene discussed is CSF1; the disease is central nervous system cancer.